New online CBT shows promise for anxious kids and teens

NCT ID NCT06661460

Recruiting now Symptom relief Sponsor: Lund University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing and testing a new internet-delivered cognitive behavioral therapy (ICBT) program for children and teens aged 8-17 with anxiety disorders. The 12-week program, guided by a therapist, uses exposure therapy to help young people face their fears. Researchers will measure changes in anxiety severity and gather feedback to improve the treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: internet-delivered cognitive behavioral therapy (ICBT)
What this could lead to: If it works, this could provide an effective, accessible treatment option for young people with anxiety disorders, reducing symptoms and improving daily life.
What could go wrong: This is a small, early-stage open trial with no control group, so results may not be definitive. The intervention may not work for all types of anxiety or may require further refinement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGORAPHOBIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agoraphobia anxiety disorder generalized anxiety disorder panic disorder phobic disorder separation anxiety disorder social phobia specific phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGORAPHOBIA ANXIETY DISORDERS (OR ANXIETY AND PHOBIC NEUROSES) GENERALIZED ANXIETY DISORDER PANIC DISORDER SEPARATION ANXIETY DISORDER SOCIAL ANXIETY DISORDER SPECIFIC PHOBIA

Contacts and locations

Locations

Barn- och ungdomshälsan, Länssjukhuset
RECRUITING

Kalmar, Region Kalmar Län, 391 85, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.